Bredt David Insider Trading Activity
Bredt David has been net-selling over the last 12 months with 0 purchases and 16 sales across 1 company.
RAPP is the most-traded position with 16 trades. The largest single transaction was a sale of RAPP for $231K on Dec 15, 2025.
Performance Scorecard
Forward stock performance after each transaction by Bredt David. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -9.2% | 44% | 18 |
| 90 days | — | -30.0% | 11% | 18 |
| 120 days | — | -36.8% | 0% | 18 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersRAPP · Rapport Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Bredt David bought and sold RAPP.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Feb 17, 2026 | RAPP | Sell | 900 | $28.02 | $25K | −0.2% | Chief Scientific Officer | |
Feb 17, 2026 | RAPP | Sell | 5,400 | $28.95 | $156K | −1.4% | Chief Scientific Officer | |
Feb 17, 2026 | RAPP | Sell | 2,200 | $29.59 | $65K | −0.6% | Chief Scientific Officer | |
Jan 15, 2026 | RAPP | Sell | 8,300 | $26.83 | $223K | −2.1% | Chief Scientific Officer | |
Jan 15, 2026 | RAPP | Sell | 200 | $27.40 | $5K | −0.1% | Chief Scientific Officer | |
Dec 31, 2025 Filed 3d late | RAPP | Sell | 6,567 | $30.05 | $197K | −1.6% | Chief Scientific Officer | |
Dec 15, 2025 | RAPP | Sell | 7,704 | $29.95 | $231K | −1.9% | Chief Scientific Officer | |
Dec 15, 2025 | RAPP | Sell | 796 | $30.68 | $24K | −0.2% | Chief Scientific Officer | |
Nov 17, 2025 | RAPP | Sell | 3,156 | $24.84 | $78K | −0.8% | Chief Scientific Officer | |
Nov 17, 2025 | RAPP | Sell | 5,344 | $25.39 | $136K | −1.3% | Chief Scientific Officer | |
Oct 15, 2025 | RAPP | Sell | 7,418 | $25.73 | $191K | −1.8% | Chief Scientific Officer | |
Oct 15, 2025 | RAPP | Sell | 1,082 | $26.16 | $28K | −0.3% | Chief Scientific Officer | |
Sep 15, 2025 | RAPP | Sell | 5,098 | $23.88 | $122K | −1.2% | Chief Scientific Officer | |
Sep 15, 2025 | RAPP | Sell | 3,402 | $24.66 | $84K | −0.8% | Chief Scientific Officer | |
Aug 15, 2025 | RAPP | Sell | 8,300 | $14.98 | $124K | −1.9% | Chief Scientific Officer | |
Aug 15, 2025 | RAPP | Sell | 200 | $15.79 | $3K | −0.0% | Chief Scientific Officer | |
Jul 15, 2025 | RAPP | Sell | 8,500 | $14.00 | $119K | −1.9% | Chief Scientific Officer | |
Jun 16, 2025 | RAPP | Sell | 8,500 | $11.00 | $94K | −1.9% | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 18 | $1.9M |
Other insiders at Rapport Therapeutics, Inc.
4 other tracked filers at RAPP.